---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252425403.md"
description: "The A-share chemical pharmaceutical sector continues to rise, with TIBET AIM PHARM hitting the limit up, and TIANYU PHARM, CSBIO, Zhendong Pharmaceutical, Menovo, JENKEM, and GuangShengTang following suit"
datetime: "2025-08-11T05:37:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252425403.md)
  - [en](https://longbridge.com/en/news/252425403.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252425403.md)
---

# 

The A-share chemical pharmaceutical sector continues to rise, with TIBET AIM PHARM hitting the limit up, and TIANYU PHARM, CSBIO, ZhenDong Pharmaceutical, Menovo, JENKEM, and GuangShengTang also following suit

### Related Stocks

- [688356.CN](https://longbridge.com/en/quote/688356.CN.md)
- [300702.CN](https://longbridge.com/en/quote/300702.CN.md)
- [603538.CN](https://longbridge.com/en/quote/603538.CN.md)
- [002826.CN](https://longbridge.com/en/quote/002826.CN.md)
- [300255.CN](https://longbridge.com/en/quote/300255.CN.md)

## Related News & Research

- [China Resources Pharmaceutical Moves to Become Largest Shareholder in Lier Chemical](https://longbridge.com/en/news/294273054.md)
- [BUZZ-Sleep apnea pill developer Apnimed poised to jump in debut after upsized IPO](https://longbridge.com/en/news/294533308.md)
- [CSPC says China NMPA accepts sirolimus albumin-bound injection filing, grants priority review](https://longbridge.com/en/news/293936243.md)
- [Shenzhen GTJA co-leads Changyu Pharma’s CNY 250 million Series D financing round](https://longbridge.com/en/news/294028268.md)
- [AEQUS: Q1 FY27 saw revenue growth but continued consolidated losses, with Aerospace leading performance](https://longbridge.com/en/news/294199674.md)